While the canonical pathway of caspase-1-mediated pyroptosis may not be operative, the activation of the NLRP3 inflammasome and the release of pro-inflammatory factors in NAFLD suggest the potential involvement of pyroptosis in NAFLD. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.